Clinical Trials Browser

Phase 4 × OTHER × Ipilimumab × Clear all

NCT06031233 2025-05-21

MINUTE

Phase 4 Recruiting

Neoplasms

NCT02068196 2023-03-24

Ipi4

Phase 4 Active not recruiting

Melanoma, Neoplasms